SB INVESTMENT ADVISERS (UK) LTD — 13F Holdings & Portfolio
CIK 1731509 · latest 13F-HR filed 2026-08-14
SB INVESTMENT ADVISERS (UK) LTD manages $7.66B in 13F-reported U.S. long-equity assets across 9 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CPNG (65.64%), GRAB (19.77%), RLAY (6.81%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 1, added to 6, and trimmed 1.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
LONDON, X0 W1K 3JP
$7.66B
Long-equity book
9
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −1 / ↑6 / ↓1
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- RELAY THERAPEUTICS INC$244.4M +88.0%
- COMPASS INC$104.3M +64.8%
- ENERGY VAULT HOLDINGS INC$21.9M +42.7%
- AURORA INNOVATION INC$15.8M +19.3%
- VIR BIOTECHNOLOGY INC$13.5M +13.7%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | COUPANG INC | CPNG | 22266T109 | $5.03B | 65.64% | 289,542,259 | SH |
| 2 | GRAB HOLDINGS LIMITED | GRAB | G4124C109 | $1.51B | 19.77% | 401,796,672 | SH |
| 3 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $522.1M | 6.81% | 27,904,963 | SH |
| 4 | COMPASS INC | COMP | 20464U100 | $265.2M | 3.46% | 21,504,702 | SH |
| 5 | VIR BIOTECHNOLOGY INC | VIR | 92764N102 | $111.6M | 1.46% | 10,948,093 | SH |
| 6 | AURORA INNOVATION INC | AUR | 051774107 | $97.4M | 1.27% | 14,279,073 | SH |
| 7 | ENERGY VAULT HOLDINGS INC | NRGV | 29280W109 | $73.2M | 0.95% | 15,535,631 | SH |
| 8 | FULL TRUCK ALLIANCE CO LTD | YMM | 35969L108 | $42.8M | 0.56% | 5,272,390 | SH |
| 9 | GINKGO BIOWORKS HOLDINGS INC | DNA | 37611X209 | $6.1M | 0.08% | 610,729 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $7.66B | 9 | 0001493152-26-038416 |
| 2026-03-31 | 2026-05-18 | $7.73B | 10 | 0001493152-26-023965 |
| 2025-12-31 | 2026-02-18 | $9.99B | 10 | 0001493152-26-007221 |
| 2025-06-30 | 2025-11-14 | $12.61B | 10 | 0001493152-25-023523 |